|
RPRD1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68560004737617E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44579999999495E-05 |
| Normal-vs-Stage2 |
2.835700E-04 |
| Normal-vs-Stage3 |
2.73339999523614E-08 |
| Normal-vs-Stage4 |
7.90549999907242E-08 |
| Stage1-vs-Stage2 |
1.786440E-01 |
| Stage1-vs-Stage3 |
1.092110E-02 |
| Stage1-vs-Stage4 |
8.036400E-03 |
| Stage2-vs-Stage3 |
5.517600E-01 |
| Stage2-vs-Stage4 |
4.642800E-01 |
| Stage3-vs-Stage4 |
8.655200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.30370003681435E-09 |
| Normal-vs-AfricanAmerican |
3.981000E-04 |
| Normal-vs-Asian |
5.523600E-02 |
| Caucasian-vs-AfricanAmerican |
6.046800E-01 |
| Caucasian-vs-Asian |
2.995700E-03 |
| AfricanAmerican-vs-Asian |
3.144400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.00390046170662E-10 |
| Normal-vs-Female |
1.003780E-04 |
| Male-vs-Female |
2.333800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.498780E-03 |
| Normal-vs-Age(41-60Yrs) |
8.35150000044749E-07 |
| Normal-vs-Age(61-80Yrs) |
3.20380000307097E-08 |
| Normal-vs-Age(81-100Yrs) |
2.295700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.540000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.582800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.882600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.747600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.259800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.875600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.744000E-01 |
| Normal-vs-Grade 2 |
1.243850E-04 |
| Normal-vs-Grade 3 |
1.8817000180249E-09 |
| Normal-vs-Grade 4 |
1.64189994933395E-10 |
| Grade 1-vs-Grade 2 |
1.504750E-01 |
| Grade 1-vs-Grade 3 |
1.826100E-02 |
| Grade 1-vs-Grade 4 |
1.076210E-03 |
| Grade 2-vs-Grade 3 |
1.189700E-02 |
| Grade 2-vs-Grade 4 |
1.623300E-04 |
| Grade 3-vs-Grade 4 |
4.776200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.601800E-03 |
| Normal-vs-ccB subtype |
1.04419994872984E-09 |
| ccA subtype-vs-ccB subtype |
1.183330E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20500000000412E-06 |
| Normal-vs-N1 |
3.106000E-02 |
| N0-vs-N1 |
4.040800E-01 |
|
|
